AzTrials
AzTrials

Postoperative Sore ThroatPhase 2/3postNCT06266481

Topical Dexamethasone Versus Topical Lidocaine Spray to Reduce POST in Shoulder Arthroscopic Surgeries: A Comparative Study

A Phase 2/3 study testing Topical dexamethasone and 10% lidocaine was sprayed over the tube for the second group in people with Postoperative Sore Throat, run by Pharos University in Alexandria at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

postoperative sore throat is the most frequent side effects after anaesthesia intubation. Dexamethasone and 10% lidocaine spray used prior to surgery has shown useful in managing these complications at the moment. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Postoperative Sore Throat
What is being tested?
Topical dexamethasone and 10% lidocaine was sprayed over the tube for the second group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
1 Mar 2024to 30 May 2024
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • •Patients belonging to ASA physical status I, II
  • Patients between age18 to 50 years
  • Patients belonging to both genders.
  • patients undergoing shoulder arthroscopic surgeries.
  • Patients with fasting blood glucose \<100 mg/dl or random blood sugar \<140 mg/dl.

Who cannot join

  • Patients who are not willing to give consent for participation in the study
  • Patients with anticipated difficult airway
  • Patients who are allergic to steroids.
  • Patients with ASA physical status III, IV
  • Diabetic patients.
  • Patients on steroids
Show all 11Show fewer
  • Patients requiring nasogastric tube or throat pack.
  • Patients posted for head and neck surgeries.
  • patient with GERD
  • Pregnant patients
  • preexisting upper respiratory tract infection.

Trial locations and contacts

1 site in 1 country.

MONA el. Mssoud, ph anesthesia contact

002+01005542232

mona.elsaid@pua.edu.eg

hatem a. attallah, ph anesthesia contact

8000000000

hatattalla@hotmail.com

Egypt1 site, 1 recruiting
  • Pharos University

    Alexandria, 21348

    mona el. massoud, ph anesthesia, 002+01005542232, mona.elsaid@pua.edu.eg

    hatem a. attalla, ph anaesthesia, 002+1001445568, hatattalla@hotmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Topical Dexamethasone Versus Topical Lidocaine Spray to Reduce Post-intubation Sore Throat in Shoulder Arthroscopic Surgeries: A Comparative Study

postoperative sore throat is the most frequent side effects after anaesthesia intubation. Dexamethasone and 10% lidocaine spray used prior to surgery has shown useful in managing these complications at the moment. In order to examine the prophylactic impact of local Dexamethasone and lidocaine on postoperative sore throat, this study was conducted.

Read the detailed description

postoperative sore throat is the most frequent side effects after anaesthesia intubation. Dexamethasone and 10% lidocaine spray used prior to surgery has shown useful in managing these complications at the moment. In order to examine the prophylactic impact of local Dexamethasone and lidocaine on postoperative sore throat, this study was conducted.In this study, 100 patients were intubated to undergo general anaesthesia for shoulder arthroscopy and randomised into one of two groups. An endotracheal tube was soaked in 8mg of dexamethasone for the first group intubation, while 10% lidocaine was sprayed over the tube for the second group. Following extubation, the two groups examined the severity of sore throats

Being tested
Topical dexamethasone, 10% lidocaine was sprayed over the tube for the second group
Keywords
Sore-throat postoperative, dexamesthsone, 10% lidocaine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Topical dexamethasoneDrug

    Patients were interviewed at 1 and 6 h after extubating for post-operative sore throat (POST). POST was assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

  • 10% lidocaine was sprayed over the tube for the second groupDrug

    Patients were interviewed at 1 and 6 h after extubating for post-operative sore throat (POST). POST was assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

Study groups in NCT06266481
Study groupRoleWhat they receive
dexamethasone groupActive comparatorAn endotracheal tube was soaked in 8mg of dexamethasone for group I intubation
Receives: Drug: Topical dexamethasone
lidocaine groupActive comparator10% lidocaine was sprayed over the tube
Receives: Drug: 10% lidocaine was sprayed over the tube for the second group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Topical dexamethasone versus topical lidocaine spray to reduce post-intubation sore throat in shoulder arthroscopic surgeries: A comparative study

    This study aimed to compare the effectiveness of topical applications of dexamethasone versus lidocaine spray in prevention sore throat.Patients will be assessed at 1 and 6 h after extubation for post-operative sore throat (POST). POST will be assessed by a modified 4-point scale (0= no sore throat, 1= mild sore throat: complains of sore throat only on asking, 2 = moderate sore throat: complains of sore throat spontaneously, and 3 = severe sore throat: change of voice or hoarseness.

    Measured: 3MONTH

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2024
  2. Study start1 Mar 2024 (estimated)
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion30 May 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06266481
Sponsor's protocol ID
pua04202312313157
Acronym
post
Status last verified
Feb 2024
First submitted
16 Jan 2024
Last updated
20 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lee JH, Kim SB, Lee W, Ki S, Kim MH, Cho K, Lim SH, Lee KM, Choi DN, Oh M. Effects of topical dexamethasone in postoperative sore throat. Korean J Anesthesiol. 2017 Feb;70(1):58-63. doi: 10.4097/kjae.2017.70.1.58. Epub 2016 Nov 25.

    PubMed 28184268
  • Banihashem N, Alijanpour E, Hasannasab B, Zarei A. Prophylactic Effects of Lidocaine or Beclomethasone Spray on Post-Operative Sore Throat and Cough after Orotracheal Intubation. Iran J Otorhinolaryngol. 2015 May;27(80):179-84.

    PubMed 26082898
  • Jabbar ML, Mahboba JH, Meazher N. Comparing the effectiveness of topical dexamethasone emollient, lidocaine gel, and glycerin emollient on the endotracheal tube for postoperative hoarseness of voice, sore throat, and laryngospasm. J Med Life. 2023 Jun;16(6):904-907. doi: 10.25122/jml-2022-0137.

    PubMed 37675167

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Topical dexamethasone and 10% lidocaine was sprayed over the tube for the second group in people with Postoperative Sore Throat, run by Pharos University in Alexandria at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact MONA el. Mssoud, ph anesthesia (002+01005542232, mona.elsaid@pua.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Topical dexamethasone versus topical lidocaine spray to reduce post-intubation sore throat in shoulder arthroscopic surgeries: A comparative study (time frame: 3MONTH). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06266481, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in